share_log

Cooper Companies | 8-K: CooperCompanies Announces Fourth Quarter and Full Year 2024 Results

Cooper Companies | 8-K: CooperCompanies Announces Fourth Quarter and Full Year 2024 Results

庫珀醫療 | 8-K:CooperCompanies公佈2024年第四季度和全年業績
美股SEC公告 ·  12/05 15:25

Moomoo AI 已提取核心訊息

Cooper Companies announced strong financial results for Q4 and full year 2024. Q4 revenue rose 10% to $1,018.4 million, with organic growth of 7%. Full year revenue increased 8% to $3.9 billion. Q4 GAAP EPS grew 38% to $0.58, while non-GAAP EPS rose 19% to $1.04.CooperVision revenue grew 9% to $676.4 million in Q4, with 8% organic growth. CooperSurgical revenue increased 12% to $342.0 million, with 5% organic growth. Gross margin improved to 67% in Q4. The company generated $268.1 million in cash from operations and $128.2 million in free cash flow during the quarter.For fiscal 2025, Cooper projects revenue of $4,080-$4,158 million, representing 6-8% organic growth. Non-GAAP EPS is expected to be $3.92-$4.02. Management expressed confidence in continued success for fiscal 2025.
Cooper Companies announced strong financial results for Q4 and full year 2024. Q4 revenue rose 10% to $1,018.4 million, with organic growth of 7%. Full year revenue increased 8% to $3.9 billion. Q4 GAAP EPS grew 38% to $0.58, while non-GAAP EPS rose 19% to $1.04.CooperVision revenue grew 9% to $676.4 million in Q4, with 8% organic growth. CooperSurgical revenue increased 12% to $342.0 million, with 5% organic growth. Gross margin improved to 67% in Q4. The company generated $268.1 million in cash from operations and $128.2 million in free cash flow during the quarter.For fiscal 2025, Cooper projects revenue of $4,080-$4,158 million, representing 6-8% organic growth. Non-GAAP EPS is expected to be $3.92-$4.02. Management expressed confidence in continued success for fiscal 2025.
庫珀醫療公佈了2024財年第四季度及全年強勁的財務業績。第四季度營業收入增長了10%,達到$101840萬,且有7%的有機增長。全年營業收入增加了8%,達到了$39億。第四季度GAAP每股收益增長了38%,達到$0.58,非GAAP每股收益增長19%,達到$1.04。庫珀視覺在第四季度的營業收入增長了9%,達到$67640萬,8%的有機增長。庫珀外科的營業收入增加了12%,達到$34200萬,增長了5%的有機增幅。第四季度毛利率提升至67%。公司在本季度內產生了$26810萬的運營現金流和$12820萬的自由現金流。對2025財年,庫珀預計營業收入在$4080-$415800萬之間,代表6-8%的有機增長。非GAAP每股收益預計在$3.92-$4.02之間。管理層對2025財年的持續成功表示信懇智能。
庫珀醫療公佈了2024財年第四季度及全年強勁的財務業績。第四季度營業收入增長了10%,達到$101840萬,且有7%的有機增長。全年營業收入增加了8%,達到了$39億。第四季度GAAP每股收益增長了38%,達到$0.58,非GAAP每股收益增長19%,達到$1.04。庫珀視覺在第四季度的營業收入增長了9%,達到$67640萬,8%的有機增長。庫珀外科的營業收入增加了12%,達到$34200萬,增長了5%的有機增幅。第四季度毛利率提升至67%。公司在本季度內產生了$26810萬的運營現金流和$12820萬的自由現金流。對2025財年,庫珀預計營業收入在$4080-$415800萬之間,代表6-8%的有機增長。非GAAP每股收益預計在$3.92-$4.02之間。管理層對2025財年的持續成功表示信懇智能。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息